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ABSTRACT  
Background: Multimorbidity and dementia are key challenges for health systems worldwide and their prevalence 
increases with age. Little is known about how multimorbidity, dementia, and increasing age combine to influence health 
outcomes or utilization.  
 
Methods: We did a retrospective population-based cohort study of all 610,457 adults aged ≥65 years residing in Alberta, 
Canada between 2002 and 2013. We used validated algorithms applied to administrative and laboratory data from the 
provincial health ministry to assess the presence/absence of dementia and 29 other morbidities, as well as clinical 
outcomes (death; emergency department visits; all-cause hospitalization) and a proxy for loss of independent living 
(discharge to long-term care). Cox and Poisson models were adjusted for year-varying covariates. 
 
Findings: Over median follow-up of 6·8 years, 153,125 (25%) participants died and 5,569 (1%) were discharged to long-
term care. At baseline, the median number of conditions was 2 (range 1 to 3). The prevalence of dementia rose over 
time by approximately 0·2% per year from 6·2% in fiscal year 2003 to 8·3% in fiscal year 2012, representing a net 
increase of approximately 13,700 people. The likelihood of all clinical outcomes (death; physician claims; emergency 
department visits; all-cause hospitalization; discharge to a long-term care facility), increased with increasing age and 
with greater burden of morbidity. The presence of dementia further increased the risk of all clinical outcomes, especially 
for mortality and discharge to a long-term care facility. The absolute proportion of participants discharged to a long-
term care facility was 0·6, 3·3 and 12·0% for those aged 65-74, 75-84, and ≥85 years respectively; among those ≥85 
years, these proportions were 1·7, 2·6 and 4·8% for those with 2, 3 or 4 morbidities but without dementia, and 28·0, 
35·6 and 37·6% for those with 2, 3 or 4 morbidities as well as dementia.  
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Interpretation: The prevalence of multimorbidity and dementia both increase with age, and older age, multimorbidity 
and dementia are all strongly correlated with adverse health outcomes as well as a proxy for loss of independent living. 
The increasing prevalences of dementia and multimorbidity over time suggest the need for coordinated national 
strategies aimed at mitigating the health challenges associated with the aging population. 
 
 
Funding: Canadian Institutes for Health Research; Alberta Innovates-Health Solutions; Canada Foundation for Innovation 
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Research in context 
Evidence before this study: We searched MEDLINE from 1969 until April 14, 2016 without language restrictions. Search 
terms were “multimorbidity OR multi-morbidity”.ti AND “dementia”.sh. Available studies demonstrate that increased 
morbidity burden is associated with higher prevalence and severity of dementia and cognitive impairment, but most 
were in select groups of patients and all were limited by relatively small sample size and lack of longitudinal follow-up 
for clinical outcomes or resource use. 
 
Added value of this study: Our large population-based study allows precise characterization of the inter-relationships 
between age, burden of chronic conditions, and dementia, as well as the joint associations between these 
characteristics and clinical outcomes. The study also demonstrates a secular increase in the prevalence of dementia 
among older adults and explores how this increase may influence use of long-term care. These results will be useful to 
policy-makers and those responsible for planning care of older adults.  
 
Implications of all the available evidence: Like multimorbidity, the prevalence of dementia increases with age, and older 
age, morbidity and dementia together are strongly correlated with adverse health outcomes and a proxy for loss of 
independent living. These findings and the secular trends in the population prevalence of multimorbidity and dementia 
all suggest the need for coordinated national strategies aimed at mitigating the challenges associated with an aging 
population. Potential areas of focus for such strategies could include health promotion, self care, tailored management 
for older patients with multimorbidity, better integration between health and social care, and ensuring an adequately 
skilled health workforce. Additional research funding will likely be needed to close knowledge gaps about how best to 
achieve these objectives. 
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INTRODUCTION 
Many people have multiple chronic conditions, which is termed multimorbidity.1 Multimorbidity is common and 
associated with worse clinical outcomes and higher health care costs, compared to good health or to the presence of a 
single chronic condition.2-5 Multimorbidity increases in parallel with age, and multimorbidity among older people is felt 
to be a key driver of health care costs and the sustainability of health systems worldwide.6 Dementia is also an age-
related condition that poses a major societal burden, and some evidence suggests that dementia is more common in the 
presence of multimorbidity.7-11 However, there are major knowledge gaps concerning the basic epidemiology of 
multimorbidity among older people; its clinical and economic consequences; the link between dementia, increasing age 
and multimorbidity; and the impact of the latter three inter-related factors on the capacity to live independently.12 
 
We used a large population-based dataset of all 610,457 people aged 65 years or greater and living in a defined 
geographical area to characterize the frequency of dementia and 29 other common chronic conditions. We examined 
the joint associations between age, dementia, and burden of morbidity with clinical outcomes (mortality, physician 
visits, emergency department visits, and hospitalizations). An important secondary goal was to describe the relationship 
between increasing age, dementia, multimorbidity, and loss of capacity for independent living, defined by discharge to a 
long-term care facility.  
 
METHODS 
This retrospective population-based cohort study is reported according to the STROBE guidelines.13 The institutional 
review boards at the Universities of Alberta and Calgary approved this study. 
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Data sources and cohort 
We used the Alberta Kidney Disease Network (AKDN) database, which incorporates data from Alberta Health (AH; the 
provincial health ministry) such as physician claims, hospitalizations and ambulatory care utilization; the Northern and 
Southern Alberta Renal Programs (NARP and SARP); and the clinical laboratories in Alberta.14 All people registered with 
AH were included in the database; all Alberta residents are eligible for insurance coverage by AH and >99% participate in 
coverage. The database was used to assemble a cohort of adults aged ≥65 years who resided in Alberta, Canada 
between May 2002 and March 2013. We followed participants from May 2002, their 65th birthday, or registration with 
AH (whichever was later) until March 2013, death, or migration out of the province.  
 
Comorbidities 
We used a previously published list of validated algorithms for 29 chronic conditions that could be applied to claims data 
and had positive predictive values ≥70%15: alcohol misuse, asthma, atrial fibrillation, lymphoma, non-metastatic cancer 
(breast, cervical, colorectal, pulmonary, and prostate), metastatic cancer, chronic heart failure, chronic pain, chronic 
obstructive pulmonary disease, chronic hepatitis B, cirrhosis, severe constipation, dementia, depression, diabetes, 
epilepsy, hypertension, hypothyroidism, inflammatory bowel disease, irritable bowel syndrome, multiple sclerosis, 
myocardial infarction, Parkinson’s disease, peptic ulcer disease, peripheral vascular disease, psoriasis, rheumatoid 
arthritis, schizophrenia, and stroke or transient ischemic attack. Dementia was one of the 29 conditions and was defined 
by the presence of 1 hospitalization or 2 physician claims within 2 years (ICD-9 290, 294·1, 331·2 or ICD-10 F00-F03, 
F05·1, G30, G31·1).16 We also considered chronic kidney disease (CKD) as a 30th condition that was defined by mean 
annual estimated glomerular filtration rate (eGFR) <60 mL/min*1·73m2 or a median annual presence of albuminuria 
(albumin:creatinine ratio ≥30 mg/g, protein:creatinine ratio ≥150 mg/g or dipstick proteinuria ≥ trace). Each participant 
was classified with respect to the presence or absence of dementia and 29 other chronic conditions for each fiscal 
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year.17 If a participant developed a condition within a fiscal year or at any point previously (lookback extended as far as 
April 1994 where records were available), they were classified as having the condition. Detailed methods for classifying 
morbidity status and the specific algorithms used are found elsewhere.15  
 
Clinical outcomes 
The primary outcome was time to all-cause death. Key secondary outcomes included the rate of physician visits (primary 
care or specialists), the rate of emergency department (ED) visits, and the rate of hospitalizations. We also evaluated 
loss of capacity for independent living, which was defined by first discharge to a long-term care facility (e.g., nursing 
homes, auxiliary hospitals) following any hospital admission.  
 
Statistical analyses 
We did analyses with Stata MP 13·1 (www.stata.com) and reported baseline (first year within follow-up) descriptive 
statistics as counts and percentages, or medians and inter-quartile ranges, as appropriate. Spine plots (multi-variable 
stacked bar graphs) were used to depict mortality, discharge to long-term care, and burden of dementia by age and 
number of morbidities. Secular trend of prevalent dementia was assessed using an autoregressive model of order 1. 
Analyses were aimed at the interactions between the specific exposures of dementia, number of non-dementia 
morbidities, and age.  
 
In order to examine the associations between dementia, increasing morbidity burden and age with the clinical 
outcomes, we used a number of models: Cox regression for mortality and long-term care placements; and generalized 
linear regression using the Poisson distribution with a log-link for the rates of physician claims, ED visits, and 
hospitalizations (all separately). For rate outcomes, we analyzed the doubling of events (claims, ED visits, and 
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hospitalizations) rather than absolute increments of 1 event. Outcomes were regressed on dementia, the number of 
other (non-dementia) morbidities (categorized as none, 1, 2, 3, 4, and 5 or more), age (categorized as 65-74, 75-84, and 
≥85 years), their 3-way interaction and all three 2-way interactions; also sex, Aboriginal status (registered First Nations 
or recognized Inuit), social assistance, and rural or urban residence. All covariates were allowed to vary on a year-by-
year basis. We also did additional analyses that further examined the oldest age groups categorized as 85-89, 90-95, and 
≥95 years.  
 
The requirement for 3-way interaction terms was confirmed by plotting the natural logarithm of the outcome ratio 
against age category for each number of morbidity groups (a separate connected line for each group) for both the 
dementia group and the group without dementia and checking for non-additive lines. We determined that the 
proportional hazard assumption was satisfied by examining plots of the log-negative-log of within-group survivorship 
probabilities versus log-time. The threshold p for statistical significance was set at 0·05. 
 
Role of the funding source 
This study is based in part by data provided by Alberta Health and Alberta Health Services. The interpretation and 
conclusions are those of the researchers and do not represent the views of the Government of Alberta. The funders had 
no role in the design or analysis of this study, nor the drafting or approval of this manuscript. Neither the Government of 
Alberta nor Alberta Health express any opinion in relation to this study. The corresponding author has access to all the 
data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. 
 
RESULTS 
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Characteristics of study participants 
Participant flow is shown in Supplemental Figure 1. There were 610,457 participants aged 65 years or greater; median 
follow-up was 6·8 years (range 1 day to 10·9 years). Participants were 53% female, median age was 66 years at baseline 
(range 65 to 110), 1% were Aboriginal, and 15% resided in a rural location (Table 1). The median number of non-
dementia morbidities was 2 (range 0 to 16); the percentage of participants with 5 or more morbidities was 9%.  
 
The prevalence of dementia rose over time by approximately 0·2% per year from 6·2% in fiscal year 2003 to 8·3% in 
fiscal year 2012, representing a net increase of approximately 13,700 people. Adjustment for mean age did not 
attenuate the prevalence of dementia over time. For all age strata, the prevalence of dementia increased in parallel with 
the number of non-dementia morbidities (Figure 1). 
 
Unadjusted likelihood of outcomes 
During follow-up, 25% of participants died and 0·9% of all participants were discharged into long-term care. The rate of 
physician claims was 1,795 per 100 person-years, the rate of ED visits was 71 per 100 person-years and hospitalization 
rate was 24 per 100 person-years. Unadjusted rates of mortality and discharge to long-term care increased with 
increasing age for people with and without dementia. Unadjusted rates of physician visits, ED visits and hospitalization 
increased with age among people without dementia, but decreased with age among those with dementia 
(Supplemental Table 1). 
 
Adjusted likelihood of outcomes 
The likelihood of all clinical outcomes (death; physician claims; ED visits; all-cause hospitalization; discharge to a long-
term care facility) tended to increase with greater burden of morbidity (Figure 2), regardless of whether dementia was 
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present or not. The exceptions were all-cause mortality (for which there was evidence of a J-shaped relation among 
those with dementia: with lowest risk of death observed among those with 2-3 morbidities) and for discharge to a long-
term care facility among people with dementia (the likelihood of which decreased with increasing morbidity) (Figure 2).  
 
The presence of dementia increased the risk of all clinical outcomes, regardless of age and level of morbidity; the excess 
risk was especially pronounced for mortality and for discharge to a long-term care facility (Figure 2). However, the 
magnitude of the excess risk for discharge to long-term care that was associated with dementia decreased with 
increasing age and morbidity (Table 2; Figure 2). For example, among people with no morbidities, the HRs for discharge 
to long-term care associated with dementia (vs no dementia) were 179·85 (127·52, 253·66), 65·57 (48·64, 88·40) and 
22·00 (17·15, 28·24) among people aged 65-74, 75-84 and ≥85 years, respectively. Among those aged ≥85 years, the HRs 
associated with dementia for discharge to long-term care among those with 1, 2 and 3 morbidities were 3·48 (3·13, 
3·88), 2·29 (2·14, 2·45) and 1·63 (1·56, 1·72) respectively. The magnitude of the excess risks for physician visits, ED visits 
or all-cause hospitalization that were associated with dementia all decreased with increasing morbidity, but were not 
consistently modified by age (Table 2; Figure 2). These patterns were also seen when only participants aged ≥85 years 
were considered (Supplemental Table 2). 
 
In contrast to these relative trends in the prognostic importance of dementia, the absolute percentages of participants 
who died and of those discharged to a long-term care facility (rather than home) increased in parallel with age and 
number of chronic conditions; the presence of dementia acted as a risk multiplier for both of these adverse outcomes, 
regardless of age or morbidity burden (Figure 3). For example, the absolute likelihood of discharge to a long-term care 
facility (over a 5-year period) was 0·6, 3·3 and 12·0% for those aged 65-74, 75-84, and ≥85 years respectively; among 
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those ≥85 years, these proportions were 1·7, 2·6, 4·8 and 10·7% for those with 2, 3, 4, or ≥5 morbidities but without 
dementia, and 28.0, 35.6, 37.6 and 46.9% for those with 2, 3, 4, or ≥5 morbidities as well as dementia. 
 
DISCUSSION 
In this population-based study of more than 600,000 community-dwelling people aged 65 years and older, we examined 
how increasing age and burden of chronic conditions modify the association between dementia and adverse health 
outcomes. As previously reported, the risk of poor outcomes increases in parallel with age and the number of 
morbidities.2, 18 We found that the presence of dementia acted as a risk multiplier across all age and morbidity strata – 
leading to worse health outcomes, especially for the risks of death or discharge to a long-term care facility. Although the 
clinical impact of dementia is already considerable, we also found a relatively slow but consistent increase in the 
prevalence of dementia over time: 0·2% per year, or approximately 13,700 people per decade in Alberta. To put this 
statistic into context, the current capacity of Alberta’s long-term care facilities is approximately 14,000 people. While 
not all people with dementia will lose the capacity to live independently, these findings have clear implications for 
health systems and those responsible for planning and providing long-term care. 
 
Previous work 
Driven by lower birth rates and longer life expectancy, the proportion of older people in the general population is 
steadily increasing worldwide.7 Longer lifetimes and the potential societal benefits associated with these demographic 
changes are to be celebrated, but population aging also poses numerous challenges for policy-makers. Although the 
age-related nature of both multimorbidity and dementia are both well known, few studies have examined how the 
interplay between these three characteristics influence health outcomes or the capacity for independent living. 
Available studies demonstrate that increased morbidity burden is associated with higher prevalence and severity of 
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dementia and cognitive impairment,8-11, 19 but are limited by relatively small sample size and lack of longitudinal follow-
up for clinical outcomes or resource use. Possible explanations for the high prevalence of comorbidities in people with 
dementia include common risk factors (e.g., unhealthy diet), a common causal pathway (e.g., atherosclerosis), adverse 
effects of medications used to treat medical morbidity, or other iatrogenic factors (e.g., subclinical stroke following 
angioplasty for coronary disease). 
 
The landmark House of Lords report entitled “Ready For Aging?” focused on the implications of the aging population for 
the UK during 2020–2030,20 and singled out dementia as an age-related condition that will require specific policy 
remedies aimed at prevention, management, harm reduction, and social inclusion. Our findings strongly validate this 
conclusion -- and suggest that there would be considerable potential benefits for national strategies on population aging 
generally and on the policy implications of dementia specifically. Potential areas of focus for such strategies could 
include health promotion (reducing the risk of dementia and other morbidities), self care (perhaps through increased 
use of technology to improve function and reduce disability) tailored care for older patients with multimorbidity 
(accounting for interactions between conditions and the medications used to treat them, as well as side effects of 
medicine that are more common with increasing age), better integration between health and social care (to delay or 
prevent loss of independent living), and ensuring that the workforce has sufficient capacity and expertise to meet the 
needs of older people.21-23 Additional research should focus on how best to achieve these objectives. 
 
Limitations 
Our study has important strengths, including its use of a large population-based database from a setting with universal 
health care coverage, its use of validated algorithms for ascertaining the presence or absence of morbidity, and its 
rigorous analytical methods. However, our study also has several potential limitations that should be considered when 
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interpreting results. First, like all studies using administrative data, residual confounding is possible by unmeasured 
characteristics such as smoking, physical activity, and the extent of support from family members and other caregivers. 
Second, since participants must use medical services to be diagnosed with chronic conditions, the use of administrative 
data to identify morbidities will underestimate the true population burden of dementia and other morbidities. In 
addition, we did not have algorithms for certain potentially important morbidities such as osteoporosis and frailty. 
However, given that utilization of medical services increases with age, our focus on people aged ≥65 years at baseline 
should reduce the extent of such underestimation. Third, when applied to ICD-10 claims, the validated algorithm that 
we used for dementia has positive predictive value of 93% and sensitivity of 67%, as compared to a clinical gold 
standard.16 Therefore, our findings will underestimate the true prevalence of dementia in Alberta. Fourth, our claims 
database only allowed us to identify people who were discharged from hospital to a long-term care facility. Since some 
older people enter long-term care facilities directly from home, our findings will underestimate the total percentage of 
people within each age stratum who eventually require long-term care. Fifth, we studied people from a single Canadian 
province and our findings may not apply to other settings, although the demographic and healthcare challenges faced 
are shared with all developed and many developing countries.  
 
Conclusions 
Like multimorbidity, the prevalence of dementia increases with increasing age, and age, morbidity and dementia 
together are strongly correlated with adverse health outcomes and a proxy for loss of independent living. These findings 
and the secular trends in the population prevalence of dementia suggest the need for coordinated national strategies to 
mitigate the health challenges associated with the aging general population. 
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Table 1. Demographic and clinical characteristics at baseline 
 All Age 65-74y Age 75-84y Age 85y+ 
Characteristic  Dementia No dementia Dementia No dementia Dementia No dementia 
N 610,457 5,424 435,151 8,652 115,957 9,772 35,501 
Male 46.8 50.3 49.6 39.1 42.5 27.6 33.8 
Aboriginal 1.4 3.1 1.6 0.6 0.6 0.4 0.5 
Rural 14.8 13.2 15.7 10.6 13.3 10.7 11.8 
Non-dementia 
morbidities 
2 (1,3) 4 (2,5) 1 (0,3) 3 (2,5) 2 (1,3) 3 (2,5) 2 (1,4) 
  None 23.0 5.5 25.6 6.7 17.8 6.6 19.2 
  One 26.3 12.1 28.0 13.9 24.8 13.6 19.5 
  Two 21.0 15.0 21.1 15.9 21.8 18.2 19.6 
  Three 13.5 16.9 12.6 17.1 15.3 19.0 15.4 
  Four 7.6 14.0 6.5 14.6 9.2 14.9 10.8 
  Five or more 8.7 36.6 6.2 31.8 11.2 27.7 15.5 
 Alcohol misuse 2.3 19.1 2.2 8.5 1.5 3.1 0.9 
 Asthma 3.0 6.7 2.7 5.2 3.5 4.5 3.6 
 Atrial fibrillation 6.9 11.9 4.5 19.5 10.6 23.4 15.5 
 Cancer, lymphoma 0.5 0.9 0.5 0.7 0.6 0.4 0.5 
 Cancer, metastatic 1.5 2.2 1.3 2.6 2.0 2.0 2.0 
 Cancer, non-metastatic 5.8 6.0 5.2 8.6 7.4 7.1 6.8 
 Chronic heart failure 8.7 20.5 5.1 28.1 13.3 37.3 24.1 
 Chronic kidney disease 18.2 29.3 17.9 22.8 16.5 28.0 21.4 
 Chronic pain 9.7 11.2 9.7 9.6 10.5 7.1 8.4 
 Chronic pulmonary 
disease 
16.3 33.6 14.1 31.3 20.1 29.0 21.2 
 Chronic viral hepatitis B 0.1 0.2 0.1 <0.1 <0.1 <0.1 <0.1 
 Cirrhosis 0.2 1.3 0.2 0.4 0.1 0.1 <0.1 
 Constipation, severe 1.5 5.7 0.9 5.7 2.0 6.2 3.5 
 Depression 7.3 34.5 6.5 27.2 6.9 19.5 6.8 
 Diabetes 16.8 29.6 16.8 23.6 16.6 17.5 13.1 
 Epilepsy 1.2 10.5 1.1 3.9 0.9 2.2 0.7 
 Hypertension 54.1 62.1 50.6 65.3 62.3 65.0 62.2 
 Hypothyroidism 11.3 16.3 10.5 18.0 12.4 18.8 13.5 
 Inflammatory bowel 
disease 
0.8 1.2 0.9 0.9 0.6 0.7 0.4 
 Irritable bowel syndrome 1.8 3.8 1.8 3.0 1.6 2.0 1.4 
 Multiple sclerosis 0.5 3.8 0.6 1.0 0.3 0.6 0.2 
 Myocardial infarction 4.3 7.9 3.8 8.0 5.1 7.2 5.8 
 Parkinson’s disease  1.4 10.6 0.7 10.8 1.9 8.2 2.4 
 Peptic ulcer disease 0.4 1.5 0.3 1.6 0.7 1.2 0.8 
 Peripheral vascular 
disease 
1.8 4.5 1.5 3.9 2.4 3.0 2.4 
 Psoriasis  0.7 1.6 0.7 0.9 0.6 0.7 0.5 
 Rheumatoid arthritis 3.0 5.0 2.6 4.7 3.7 4.5 3.7 
 Schizophrenia  0.9 16.2 0.7 6.0 0.4 3.4 0.3 
 Stroke or TIA 9.6 30.8 6.9 33.8 12.6 33.6 17.8 
        
N count, TIA transient ischemic attack 
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Percentages and median (inter-quartile range) as appropriate. 
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Table 2. Adjusted risk multiplier for dementia by age and number of morbidities 
Morbidities No of  
participant-years 
(%) 
Mortality Physician 
visits 
 
ED visits Hospitalizations 
 
Discharge to 
long-term care 
  HR (95%CI) RR (95%CI) RR (95%CI) RR (95%CI) HR (95%CI) 
       
Age 65-74y 2,093,043      
  None 409,872 (19.6) 6.38 (5.86,6.95) 1.79 (1.73,1.85) 2.40 (2.14,2.70) 5.22 (4.38,6.22) 179.85 (127.52,253.66) 
  One 514,511 (24.6) 5.02 (4.74,5.31) 1.29 (1.27,1.32) 2.07 (1.94,2.20) 4.02 (3.70,4.38) 63.74 (53.52,75.91) 
  Two 462,717 (22.1) 4.43 (4.23,4.63) 1.23 (1.21,1.25) 1.93 (1.84,2.02) 3.14 (2.95,3.33) 28.52 (25.34,32.10) 
  Three 320,038 (15.3) 3.41 (3.27,3.56) 1.21 (1.19,1.23) 1.65 (1.59,1.71) 2.70 (2.57,2.83) 11.54 (10.51,12.68) 
  Four 183,217 (8.8) 2.55 (2.44,2.66) 1.20 (1.18,1.22) 1.46 (1.41,1.51) 2.19 (2.09,2.28) 5.41 (4.99,5.88) 
  Five or more 202,688 (9.7) 1.80 (1.76,1.84) 1.20 (1.19,1.21) 1.35 (1.33,1.38) 1.79 (1.75,1.83) 2.16 (2.07,2.26) 
       
Age 75-84y 1,441,821      
  None 146,923 (10.2) 4.68 (4.46,4.91) 1.87 (1.83,1.92) 2.80 (2.60,3.01) 5.98 (5.36,6.67) 65.57 (48.64,88.40) 
  One 240,053 (16.7) 3.66 (3.55,3.77) 1.31 (1.29,1.32) 1.95 (1.88,2.03) 3.52 (3.33,3.72) 18.20 (15.93,20.79) 
  Two 301,412 (20.9) 3.19 (3.12,3.27) 1.23 (1.22,1.24) 1.75 (1.70,1.80) 2.99 (2.88,3.10) 6.41 (5.94,6.92) 
  Three 271,780 (18.9) 2.74 (2.68,2.80) 1.21 (1.20,1.22) 1.54 (1.50,1.57) 2.45 (2.38,2.53) 3.73 (3.52,3.95) 
  Four 191,442 (13.3) 2.31 (2.26,2.36) 1.20 (1.19,1.21) 1.42 (1.39,1.45) 2.03 (1.98,2.08) 2.12 (2.02,2.23) 
  Five or more 290,211 (20.1) 1.74 (1.72,1.76) 1.20 (1.20,1.21) 1.27 (1.25,1.28) 1.61 (1.59,1.63) 1.30 (1.26,1.33) 
       
Age 85y+ 610,548      
  None 70,565 (11.6) 6.48 (6.18,6.79) 4.48 (4.37,4.59) 4.71 (4.33,5.12) 10.48 (9.24,11.89) 22.00 (17.15,28.24) 
  One 60,779 (10.0) 2.20 (2.13,2.26) 1.50 (1.48,1.52) 1.73 (1.65,1.80) 3.12 (2.93,3.32) 3.48 (3.13,3.88) 
  Two 97,128 (15.9) 2.14 (2.10,2.19) 1.35 (1.34,1.37) 1.48 (1.44,1.52) 2.53 (2.44,2.63) 2.29 (2.14,2.45) 
  Three 107,891 (17.7) 2.03 (1.99,2.07) 1.30 (1.29,1.31) 1.27 (1.25,1.30) 2.01 (1.95,2.07) 1.63 (1.56,1.72) 
  Four 93,241 (15.3) 1.85 (1.81,1.88) 1.26 (1.25,1.27) 1.18 (1.16,1.20) 1.60 (1.56,1.65) 1.26 (1.21,1.31) 
  Five or more 180,944 (29.6) 1.54 (1.52,1.55) 1.23 (1.23,1.24) 1.09 (1.07,1.10) 1.32 (1.30,1.34) 1.08 (1.06,1.11) 
       
CI confidence interval, HR hazard ratio, RR rate ratio, ED emergency department 
 
Ratios are adjusted for sex, Aboriginal status, and rural/urban. These models include 3-way and 2-way interactions terms for dementia, age, and 
number of morbidity.  
 
The Table shows the likelihood of a two-fold increase in the risk of the outcomes with repeat events (i.e., physician visits, ED visits, 
hospitalizations) that is associated with dementia, along with the risk of mortality and discharge to long-term care. For example, in those who 
are aged 65-74y with no comorbidities, the presence of dementia is 1.83 times more likely to be associated with a two-fold increase in the 
number of physician visits, compared to those of similar age and with no comorbidities, but without dementia. 
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Figure 1. Relative proportion with dementia in fiscal year 2011 by age and number of morbidities 
 
The top row, from left to right, shows participants aged 65-74y, aged 75-84y, and age 85y+. The bottom row, from left to right, shows participants aged 85-89y, 
aged 90-94y, and age 95y+. Within each graph, the bars from left to right show the number of morbidities that each group has, starting at 0 morbidities and 
ending at 5 or more. The width of each bar shows the percentage of participants in each group. The height of each bar shows the unadjusted percentage of 
participants with dementia (orange), and the percentage of participants without dementia (green). 
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Figure 2. Adjusted risk multiplier for number of morbidities by age and presence of dementia 
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ED emergency department, LTC long-term care 
The risk multipliers are presented by age, number of morbidities and dementia. They are adjusted for the number of morbidities, dementia, age, sex, 
Aboriginal status, and rural/urban, and are relative to people aged 65-74 years with no non-dementia morbidities. These models include 3-way and 2-way 
interactions terms for dementia, age, and number of morbidity. The first panel shows the hazards ratios for mortality in by the number of morbidities. The 
second, third, and fourth panels similarly show the rate ratios for physician visits, ED visits, and hospitalizations, respectively. The last panel shows the hazard 
ratios for discharge to long-term care from hospital. The blue diamond symbols show those with dementia and the red squares show those without dementia. 
The horizontal bars depict 95% confidence intervals. 
 
Along with the risk of mortality and discharge to long-term care, the Figure shows the likelihood of a two-fold increase in the risk of the outcomes with repeat 
events (i.e., physician visits, ED visits, hospitalizations) that is associated with dementia. For example, in those, who are aged 65-74 with no dementia but one 
comorbidity is 1.57 times more likely to be associated with a two-fold increase in the number of physician visits, compared to those of similar age, also with no 
dementia but with no comorbidities. 
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Figure 3. Relative proportion of deaths vs discharges to long-term facility after 5 years by age, presence/absence of dementia, and 
number of morbidities 
 
LTC long-term care 
 
For this analysis, age and the presence/absence of dementia and other morbidities were assessed in fiscal year 2006. Clinical status (death; discharge to long-
term care facility) was assessed 5 years later in fiscal year 2011. The top row shows participants with no dementia. The bottom row shows participants with 
dementia. The left-most column shows participants 65-74y, the middle column shows participants 75-84y, and the right-most column shows participants 85y+. 
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Within each graph, the bars from left to right show the number of morbidities by group, starting at 0 morbidities and ending at 5 or more. The width of each 
bar shows the percentage of participants in each group. The height of each bar shows clinical status – the unadjusted percentage of participants that are alive 
without discharge to a long-term care facility (dark blue), alive but discharged to a long-term care placement after a hospitalization (light blue), deceased but 
discharged to a long-term care placement previously (light green), deceased and never discharged to a long-term care placement (dark green). 
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Supplemental Table 1. Unadjusted event rates over follow-up 
 All Age 65-74y Age 75-84y Age 85y+ 
Characteristic  Dementia No dementia Dementia No dementia Dementia No dementia 
N 610,457 5,424 435,151 8,652 115,957 9,772 35,501 
Mortality 21.6 43.6 10.5 59.6 22.4 75.7 39.2 
Physician visits 1,795.0 4,890.1 1,393.1 4,404.4 1,795.1 4,318.9 1,845.4 
ED visits 70.7 148.3 55.1 140.5 73.4 127.0 89.2 
Hospitalizations 24.4 73.5 15.9 71.5 24.6 64.8 32.4 
Discharge to long-term 
care 
3.7 22.6 0.4 31.6 1.2 44.7 4.2 
        
N count. Rates are per 100 person-years 
ED emergency department 
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Supplemental Table 2. Adjusted risk multiplier for dementia by age and number of morbidities in the oldest 
participants 
Morbidities No of  
participant-
years (%) 
Mortality Physician 
visits 
 
ED visits Hospitalizations 
 
Discharge to 
long-term care 
  HR (95%CI) RR (95%CI) RR (95%CI) RR (95%CI) HR (95%CI) 
       
Age 85-89 y 371,349      
  None 31,025 (8.4) 4.37 (4.09,4.66) 3.47 (3.35,3.59) 4.06 (3.64,4.52) 7.79 (6.62,9.16) 35.15 (24.65,50.13) 
  One 40,346 (10.9) 2.14 (2.06,2.23) 1.46 (1.43,1.48) 1.83 (1.74,1.94) 3.29 (3.04,3.56) 8.24 (7.00,9.69) 
  Two 63,481 (17.1) 2.14 (2.08,2.20) 1.30 (1.29,1.32) 1.63 (1.57,1.69) 2.67 (2.54,2.81) 4.90 (4.43,5.42) 
  Three 68,628 (18.5) 2.03 (1.98,2.09) 1.25 (1.24,1.27) 1.45 (1.41,1.49) 2.27 (2.18,2.36) 2.98 (2.76,3.21) 
  Four 57,909 (15.6) 1.87 (1.82,1.92) 1.22 (1.20,1.23) 1.31 (1.27,1.34) 1.78 (1.71,1.84) 1.86 (1.75,1.98) 
  Five or more 109,960 (29.6) 1.53 (1.51,1.56) 1.21 (1.20,1.22) 1.21 (1.19,1.23) 1.47 (1.44,1.50) 1.29 (1.25,1.33) 
       
Age 90-94 y 168,388      
  None 18,149 (10.8) 6.35 (5.85,6.89) 6.05 (5.79,6.33) 5.38 (4.66,6.22) 12.15 (9.67,15.27) 30.10 (19.04,47.57) 
  One 15,026 (8.9) 1.96 (1.87,2.06) 1.67 (1.63,1.71) 1.72 (1.60,1.85) 2.94 (2.64,3.28) 4.44 (3.69,5.35) 
  Two 25,454 (15.1) 1.86 (1.79,1.93) 1.43 (1.41,1.45) 1.44 (1.37,1.51) 2.51 (2.35,2.68) 2.53 (2.27,2.82) 
  Three 29,431 (17.5) 1.77 (1.72,1.83) 1.34 (1.32,1.36) 1.22 (1.17,1.26) 1.87 (1.77,1.96) 1.93 (1.78,2.10) 
  Four 26,489 (15.7) 1.64 (1.58,1.69) 1.29 (1.28,1.31) 1.15 (1.11,1.19) 1.56 (1.50,1.63) 1.40 (1.31,1.49) 
  Five or more 53,839 (32.0) 1.42 (1.39,1.45) 1.24 (1.23,1.26) 1.02 (1.00,1.04) 1.21 (1.18,1.24) 1.11 (1.07,1.15) 
       
Age 95 y+ 70,811      
  None 21,391 (30.2) 19.57 (17.36,22.06) 25.60 (23.89,27.44) 14.04 (11.17,17.65) 26.93 (19.01,38.15) 54.52 (31.64,93.94) 
  One 5,407 (7.6) 2.12 (1.97,2.29) 2.05 (1.96,2.13) 1.46 (1.29,1.65) 2.21 (1.84,2.66) 2.14 (1.72,2.67) 
  Two 8,193 (11.6) 1.69 (1.60,1.79) 1.61 (1.57,1.66) 1.15 (1.06,1.24) 1.69 (1.50,1.89) 1.78 (1.54,2.06) 
  Three 9,832 (13.9) 1.60 (1.52,1.68) 1.45 (1.42,1.49) 0.95 (0.89,1.01) 1.28 (1.17,1.39) 1.16 (1.05,1.29) 
  Four 8,843 (12.5) 1.40 (1.33,1.48) 1.36 (1.33,1.39) 0.90 (0.85,0.95) 1.03 (0.95,1.11) 1.04 (0.95,1.14) 
  Five or more 17,145 (24.2) 1.35 (1.30,1.40) 1.29 (1.26,1.31) 0.90 (0.87,0.93) 1.02 (0.98,1.07) 0.98 (0.92,1.03) 
       
CI confidence interval, HR hazard ratio, RR rate ratio, ED emergency department  
 
Ratios are adjusted for sex, Aboriginal status, and rural/urban. These models include 3-way and 2-way interactions terms for dementia, age, 
and number of morbidities.  
 
The Table shows the likelihood of a two-fold increase in the risk of the outcomes with repeat events (i.e., physician visits, ED visits, 
hospitalizations) that is associated with dementia, along with the risk of mortality and discharge to long-term care. For example, in those who 
are aged 85-89y with no comorbidities, the presence of dementia is 3.47 times more likely to be associated with a two-fold increase in the 
number of physician visits, compared to those of similar age and with no comorbidities, but without dementia. 
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Supplemental Figure 1. Participant flow diagram 
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